LB: New data on safety and efficacy of COVID vaccination
12 July 2021
•
S196
•
17:15
>
18:15
•
LB: New data on safety and efficacy of COVID vaccination
•
12a. COVID-19
17:15
•
4722
•
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalised COVID-19 patients in Israel
>
T.
Tal
BROSH-NISSIMOV (Ashdod)
17:25
•
4663
•
Outbreak of SARS-CoV-2 infection in a long-term care facility after full COVID-19 vaccination: risk factors assessment
>
M.
Martin
MARTINOT (Colmar)
17:35
•
4751
•
Global patient safety database analysis: thrombotic events with thrombocytopenia after second dose of COVID-19 vaccine
>
M.
Magnus
NORD (Mölndal)
17:45
•
4826
•
The impact of the BNT162b2 vaccine on kidney transplant and chronic dialysis patients: initial report from the COVID-19 mRNA vaccine immunogenicity in patients with end stage renal disease; the Jerusalem COVIReD Study
>
Y.
Yonatan
OSTER (Jerusalem)
17:55
•
4975
•
Safety of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines
>
E.
Eva P.
GALIZA (London)
18:05
•
INT111
•
Q&A/Discussion
|